TIDMGSK

RNS Number : 1450Z

GlaxoSmithKline PLC

20 January 2022

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Dr H Barron 
====  ========================================  ==================================================== 
 b)    Position/status                          Chief Scientific Officer and President, 
                                                 R&D 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Acquisition of ADSs following the re-investment 
        transaction                              of dividends paid to shareholders on 13 
                                                 January 2022 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $46.2266                1,080.147 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2022-01-19 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr J Ford 
====  ========================================  ==================================================== 
 b)    Position/status                          SVP & General Counsel 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Acquisition of ADSs following the re-investment 
        transaction                              of dividends paid to shareholders on 13 
                                                 January 2022 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $46.2266                105.881 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2022-01-19 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Mr B McNamara 
====  ========================================  ==================================================== 
 b)    Position/status                          CEO, GSK Consumer Healthcare 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Acquisition of ADSs following the re-investment 
        transaction                              of dividends paid to shareholders on 13 
                                                 January 2022 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $46.2266                1,501.563 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2022-01-19 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                     Shobie Ramakrishnan 
====  ========================================  ==================================================== 
 b)    Position/status                          Chief Digital & Technology Officer 
====  ========================================  ==================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ==================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ==================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ==================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ==================================================== 
 b)    Nature of the                            Acquisition of ADSs following the re-investment 
        transaction                              of dividends paid to shareholders on 13 
                                                 January 2022 
====  ========================================  ==================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ========================= 
                                                 $46.2266                9.000 
                                                 ======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ======================================================== 
 e)    Date of the transaction                  2022-01-19 
====  ========================================  ==================================================== 
 f)    Place of the                             New York Stock Exchange (XNYS) 
        transaction 
====  ========================================  ==================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEBLFLLFLEBBV

(END) Dow Jones Newswires

January 20, 2022 10:59 ET (15:59 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more Gsk Charts.